Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?-Reference-Cited by-同舟云学术

Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?

Published:2018-05-09 Issue:5 Volume:122 Page:794-800
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Bryant Richard J.¹²^ORCID,Yang Bob¹^ORCID,Philippou Yiannis¹,Lam Karla¹,Obiakor Maureen¹,Ayers Jennifer¹,Chiocchia Virginia²³,Gleeson Fergus⁴,MacPherson Ruth⁴,Verrill Clare²⁵,Sooriakumaran Prasanna²⁶,Hamdy Freddie C.¹²,Brewster Simon F.¹

Affiliation:

1. Department of Urology; Oxford University Hospitals NHS Foundation Trust; Oxford UK

2. Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

3. National Perinatal Epidemiology Unit; Nuffield Department of Population Health; University of Oxford; Oxford UK

4. Department of Radiology; Oxford University Hospitals NHS Foundation Trust; Oxford UK

5. Oxford NIHR Biomedical Research Centre; University of Oxford; Oxford UK

6. Department of Uro-Oncology; University College London Hospital NHS Foundation Trust; London UK

Funder

Oxford National Institute of Health Research Biomedical Research Centre

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14248/fullpdf

Reference40 articles.

1. Active surveillance for prostate cancer: patient selection and management;Klotz;Curr Oncol,2010

2. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA,2015

3. Active surveillance for prostate cancer: current evidence and contemporary state of practice;Tosoian;Nat Rev Urol,2016

4. Early detection of prostate cancer: AUA Guideline;Carter;J Urol,2013

5. Active surveillance for the management of localized prostate cancer (cancer care Ontario guideline): American society of clinical oncology clinical practice guideline endorsement;Chen;J Clin Oncol,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

2. The role of multiparametric magnetic resonance in active surveillance of a low‐risk prostate cancer cohort from clinical practice;The Prostate;2023-03-09

3. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection;European Urology Focus;2023-03

4. Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer;World Journal of Urology;2022-03-26

5. Current Imaging Modalities to Assess Prostate Cancer;Robotic Urologic Surgery;2022